Predictions
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€127.44
17.01.20
17.01.20
€160.00
04.11.21
04.11.21
83.69%
05.11.21
05.11.21
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.00
22.12.19
22.12.19
€79.00
04.11.21
04.11.21
-3.61%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
AbbVie Inc.
Start price
Target price
Perf. (%)
€73.20
01.11.19
01.11.19
€98.00
04.11.21
04.11.21
37.84%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€257.80
25.10.19
25.10.19
€300.00
04.11.21
04.11.21
-6.13%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€92.55
02.09.19
02.09.19
€110.00
04.11.21
04.11.21
67.24%
05.11.21
05.11.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€99.11
11.07.19
11.07.19
€160.75
04.11.21
04.11.21
136.20%
05.11.21
05.11.21
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€235.41
17.01.19
17.01.19
€419.00
04.11.21
04.11.21
67.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Align Technology
Start price
Target price
Perf. (%)
€194.93
27.11.18
27.11.18
€558.00
04.11.21
04.11.21
201.95%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€44.54
27.12.18
27.12.18
€53.22
04.11.21
04.11.21
14.78%
05.11.21
05.11.21
Align Technology
Start price
Target price
Perf. (%)
€289.85
11.10.18
11.10.18
€455.96
04.11.21
04.11.21
103.07%
05.11.21
05.11.21
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€47.22
19.04.18
19.04.18
€62.00
04.11.21
04.11.21
8.26%
05.11.21
05.11.21
Abbott Laboratories
Start price
Target price
Perf. (%)
€86.80
20.04.20
20.04.20
€120.00
04.11.21
04.11.21
28.11%
04.11.21
04.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.89
09.01.21
09.01.21
€68.00
09.01.22
09.01.22
8.15%
30.10.21
30.10.21
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€71.50
01.03.19
01.03.19
€77.00
04.11.21
04.11.21
-1.04%
26.10.21
26.10.21
Could be worthwhile Investment >10% per year
Becton, Dickinson & Co.
Start price
Target price
Perf. (%)
€222.00
01.02.21
01.02.21
€260.00
30.03.22
30.03.22
-6.17%
09.10.21
09.10.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€39.50
28.08.21
28.08.21
-
28.08.22
28.08.22
0.10%
04.09.21
04.09.21
Risky Investment
Humana Inc.
Start price
Target price
Perf. (%)
€370.00
01.05.21
01.05.21
-
01.05.22
01.05.22
-5.65%
02.09.21
02.09.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
Pfizer Inc.
Start price
Target price
Perf. (%)
€31.50
30.11.20
30.11.20
€38.00
30.11.21
30.11.21
18.40%
02.08.21
02.08.21
Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group